Nobuhiro Maekawa Selected Research

Septic Shock (Toxic Shock Syndrome)

10/2007	Urinary trypsin inhibitor reduces inflammatory response in kidney induced by lipopolysaccharide.
1/2005	Mixed bacterial infection model of sepsis in rabbits and its application to evaluate superantigen-adsorbing device.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nobuhiro Maekawa Research Topics

Disease

4	Necrosis 05/2013 - 11/2009
4	Ischemia 11/2009 - 10/2007
3	Acute Kidney Injury (Acute Renal Failure) 01/2015 - 11/2009
3	Inflammation (Inflammations) 05/2013 - 12/2012
2	Infections 01/2015 - 09/2010
2	Sepsis (Septicemia) 01/2015 - 01/2005
2	Body Weight (Weight, Body) 05/2013 - 01/2013
2	Reperfusion Injury 01/2013 - 01/2008
2	Anaphylaxis (Anaphylactic Shock) 07/2012 - 06/2010
2	Learning Disabilities (Learning Disability) 12/2011 - 09/2010
2	Septic Shock (Toxic Shock Syndrome) 10/2007 - 01/2005
1	Acidosis 03/2011
1	Lactic Acidosis 03/2011
1	Fever (Fevers) 09/2010
1	Urticaria (Hives) 06/2010
1	Hyperglycemia 11/2009
1	Wounds and Injuries (Trauma) 05/2009
1	Pulmonary Atelectasis 03/2008
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 10/2007
1	Pancreatitis 10/2007
1	Insulin Resistance 05/2007
1	Hyponatremia 05/2007
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2007
1	Carotid-Cavernous Sinus Fistula 01/2007
1	Cleft Lip (Harelip) 01/2007
1	Neoplasms (Cancer) 07/2006
1	Bacterial Infections (Bacterial Infection) 01/2005
1	Shock 01/2005
1	Coinfection 01/2005

Drug/Important Bio-Agent (IBA)

3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2015 - 10/2007
3	Ribose (D-Ribose)IBA 01/2013 - 05/2009
2	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2015 - 11/2012
2	CytokinesIBA 01/2015 - 10/2007
2	LipopolysaccharidesIBA 01/2015 - 10/2007
2	Cisplatin (Platino)FDA LinkGeneric 05/2013 - 01/2013
2	MonosaccharidesIBA 01/2013 - 05/2009
2	Glucose (Dextrose)FDA LinkGeneric 11/2009 - 05/2007
2	alloseIBA 05/2009 - 10/2007
2	urinastatin (MR 20)IBA 01/2008 - 10/2007
1	HMGB ProteinsIBA 01/2015
1	3- (5- (4- (cyclopentyloxy)- 2- hydroxybenzoyl)- 2- ((3- hydroxy- 1,2- benzisoxazol- 6- yl)methoxy)phenyl)propionic acidIBA 01/2015
1	CurcuminIBA 05/2013
1	CarbonIBA 01/2013
1	HMGB1 Protein (HMG1)IBA 12/2012
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 12/2012
1	Alanine Transaminase (SGPT)IBA 12/2012
1	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 12/2012
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 12/2012
1	EndotoxinsIBA 11/2012
1	SugammadexIBA 07/2012
1	Erythropoietin FDA Link 12/2011
1	Isoflurane FDA LinkGeneric 12/2011
1	Sodium Bicarbonate (Baking Soda)FDA LinkGeneric 03/2011
1	Cefotiam FDA Link 06/2010
1	Vasoconstrictor AgentsIBA 06/2010
1	CreatinineIBA 11/2009
1	NitrogenIBA 11/2009
1	Urea (Carbamide)FDA LinkGeneric 11/2009
1	salicylhydroxamic acid (SHAM)IBA 05/2009
1	Saline SolutionIBA 01/2008
1	Oxygen (Dioxygen)IBA 01/2008
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 10/2007
1	Pharmaceutical PreparationsIBA 10/2007
1	SuperantigensIBA 01/2005
1	Staphylococcal enterotoxin FIBA 01/2005

Therapy/Procedure

2	Therapeutics 03/2011 - 01/2005
2	Intraperitoneal Injections 11/2009 - 01/2005
1	Minor Surgical Procedures (Minor Surgery) 09/2010
1	Anesthesia 09/2010
1	Operative Surgical Procedures 11/2009
1	Nephrectomy 11/2009
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 03/2008
1	General Anesthesia 03/2008
1	Perioperative Period 05/2007
1	Osteotomy 01/2007
1	Adrenalectomy 07/2006
1	Ligation 01/2005
1	Punctures 01/2005